Safety of Combining Celecoxib with Paracetamol and Orphenadrine Citrate

Evidence Supporting This Combination

The American College of Rheumatology specifically recommends acetaminophen (paracetamol) as an adjunct for supplemental analgesia beyond a single NSAID, rather than adding a second NSAID which would significantly increase cardiovascular and gastrointestinal risks 1
There are no documented drug interactions between orphenadrine and celecoxib that would contraindicate their concurrent use 2

Monitor blood pressure during treatment, as celecoxib can increase BP by approximately 5 mmHg 1, 2
Use celecoxib at the lowest effective dose for the shortest duration necessary—your 5-day course aligns with this recommendation 2
Be alert for cardiovascular thrombotic events including chest pain, shortness of breath, or neurological symptoms 1
The 5-day duration significantly reduces GI risk compared to chronic use 2
Consider adding a proton pump inhibitor if the patient has: history of GI ulcers, age ≥65 years, concurrent low-dose aspirin use, or concurrent anticoagulant therapy 1, 2

Do not use this combination if the patient has severe renal disease or cirrhosis 3, 2
Do not use this combination if the patient has recent myocardial infarction (within past year) 2
Do not use this combination if the patient has active GI bleeding or unhealed peptic ulcer 2

Monitor for dehydration, especially if the patient has pre-existing renal disease, heart failure, or hypertension 3, 2
Approximately 2% of patients develop renal complications with NSAID therapy, though this risk is primarily with chronic use 1, 3

The combination avoids the dangerous practice of using multiple NSAIDs simultaneously, which increases GI complications 2-3.5-fold in elderly patients 1
Paracetamol has minimal drug interactions and no common contraindications, making it an ideal adjunct 4

The short 5-day duration minimizes all potential risks while providing adequate symptomatic relief 2